<DOC>
	<DOCNO>NCT00002625</DOCNO>
	<brief_summary>Phase I trial study effectiveness topotecan radiation therapy treat patient solid tumor lymphoma . Drugs use chemotherapy use different way stop cancer cell divide stop grow die . Radiation therapy use high-energy x-rays damage cancer cell . Combining chemotherapy radiation therapy may kill cancer cell .</brief_summary>
	<brief_title>Topotecan Radiation Therapy Treating Patients With Solid Tumors Lymphoma</brief_title>
	<detailed_description>OBJECTIVES : I . Define maximum tolerate dose safety profile topotecan ( TOPO ) administer daily high-dose thoracic radiotherapy total 60 Gy patient solid tumor lymphoma . II . Assess qualitative quantitative nature toxic effect encounter treatment . III . Estimate tissue tumor TOPO concentration radiotherapy evaluate plasma TOPO level . IV . Evaluate , use Western blot immunohistochemical stain , effect TOPO/radiotherapy topoisomerase I level peripheral blood lymphocyte ( PBL ) . V. Determine whether TOPO induces apoptosis PBL patient population . VI . Examine tumor tissue pre- post-treatment ( available ) topoisomerase I level , DNA damage , topoisomerase I/DNA complex , apoptotic event . OUTLINE : Radiosensitization plus Radiotherapy . Topotecan , TOPO , NSC-609699 ; plus external-beam irradiation use linear accelerator photon energies 4 10 MV ( electron acceptable boost field ) .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Topotecan</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Microscopically confirm solid tumor lymphoma potentially curable conventional surgery radiotherapy Previously unirradiated disease schedule receive thoracic irradiation 60 Gy , include pulmonary esophageal tumor No metastatic disease effectively treat systemic chemotherapy No history brain metastasis PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 0 1 WBC least 4,000 ANC least 1,500 Platelets least 100,000 Bilirubin great 1.5 mg/dL Creatinine great 1.5 mg/dL Calcium great 11.0 mg/dL No pregnant nursing woman Pregnancy test require , appropriate Effective contraception require fertile patient PRIOR CONCURRENT THERAPY : At least 4 week since chemotherapy ( 6 week since nitrosoureas mitomycin ) recover At least 4 week since radiotherapy recover</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>stage III adult Hodgkin lymphoma</keyword>
	<keyword>stage IV adult Hodgkin lymphoma</keyword>
	<keyword>recurrent non-small cell lung cancer</keyword>
	<keyword>recurrent adult Hodgkin lymphoma</keyword>
	<keyword>recurrent esophageal cancer</keyword>
	<keyword>stage III cutaneous T-cell non-Hodgkin lymphoma</keyword>
	<keyword>stage IV cutaneous T-cell non-Hodgkin lymphoma</keyword>
	<keyword>recurrent cutaneous T-cell non-Hodgkin lymphoma</keyword>
	<keyword>recurrent small cell lung cancer</keyword>
	<keyword>stage III grade 1 follicular lymphoma</keyword>
	<keyword>stage III grade 2 follicular lymphoma</keyword>
	<keyword>stage III grade 3 follicular lymphoma</keyword>
	<keyword>stage III adult diffuse small cleave cell lymphoma</keyword>
	<keyword>stage III adult diffuse mixed cell lymphoma</keyword>
	<keyword>stage III adult diffuse large cell lymphoma</keyword>
	<keyword>stage III adult immunoblastic large cell lymphoma</keyword>
	<keyword>stage III adult lymphoblastic lymphoma</keyword>
	<keyword>stage III adult Burkitt lymphoma</keyword>
	<keyword>stage IV grade 1 follicular lymphoma</keyword>
	<keyword>stage IV grade 2 follicular lymphoma</keyword>
	<keyword>stage IV grade 3 follicular lymphoma</keyword>
	<keyword>stage IV adult diffuse small cleave cell lymphoma</keyword>
	<keyword>stage IV adult diffuse mixed cell lymphoma</keyword>
	<keyword>stage IV adult diffuse large cell lymphoma</keyword>
	<keyword>stage IV adult immunoblastic large cell lymphoma</keyword>
	<keyword>stage IV adult lymphoblastic lymphoma</keyword>
	<keyword>stage IV adult Burkitt lymphoma</keyword>
	<keyword>recurrent grade 1 follicular lymphoma</keyword>
	<keyword>recurrent grade 2 follicular lymphoma</keyword>
	<keyword>recurrent grade 3 follicular lymphoma</keyword>
	<keyword>recurrent adult diffuse small cleave cell lymphoma</keyword>
	<keyword>recurrent adult diffuse mixed cell lymphoma</keyword>
	<keyword>recurrent adult diffuse large cell lymphoma</keyword>
	<keyword>recurrent adult immunoblastic large cell lymphoma</keyword>
	<keyword>recurrent adult lymphoblastic lymphoma</keyword>
	<keyword>recurrent adult Burkitt lymphoma</keyword>
	<keyword>stage III adult T-cell leukemia/lymphoma</keyword>
	<keyword>stage IV adult T-cell leukemia/lymphoma</keyword>
	<keyword>recurrent adult T-cell leukemia/lymphoma</keyword>
	<keyword>stage III mantle cell lymphoma</keyword>
	<keyword>stage IV mantle cell lymphoma</keyword>
	<keyword>recurrent mantle cell lymphoma</keyword>
	<keyword>recurrent marginal zone lymphoma</keyword>
	<keyword>recurrent small lymphocytic lymphoma</keyword>
	<keyword>stage III small lymphocytic lymphoma</keyword>
	<keyword>stage III marginal zone lymphoma</keyword>
	<keyword>stage IV small lymphocytic lymphoma</keyword>
	<keyword>stage IV marginal zone lymphoma</keyword>
	<keyword>extranodal marginal zone B-cell lymphoma mucosa-associated lymphoid tissue</keyword>
	<keyword>nodal marginal zone B-cell lymphoma</keyword>
	<keyword>splenic marginal zone lymphoma</keyword>
</DOC>